UNSPSC 51383903: Flunixin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H11F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 356IB1O400, chemically known as 3-pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)- but generally known as flunixin, which bears US NIH Compound Identifier 38081. European Medicines Agency schedules Flunixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07711MIG.

UNSPSC 51383903 Flunixin is a Commodity code that covers pharmaceutical products purchased by state and local health agencies, though recent solicitation activity under this code designation shows limited alignment with the nominal scope. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—emergency response and harm-reduction pharmaceuticals rather than flunixin, an equine and livestock anti-inflammatory drug. The mismatch suggests either a data-entry error in the county's tagging or a misalignment between the code's intended scope and actual procurement categorization. The Seminole County solicitation required electronic bid submission through the county's e-Procurement Portal, with unit-price proposals for each line item. Contract terms included a two-year initial period with a one-year renewal option, quarterly deliveries to the Community Health Building in Sanford, and standard compliance requirements such as drug-free workplace certification, E-Verify verification, workers' compensation insurance, commercial general liability, and professional liability coverage. The procurement indicated potential FEMA funding, which triggered adherence to federal environmental regulations and audit provisions.

Flunixin activity in recent state and local procurement is sparse and does not reflect sustained buying patterns across multiple jurisdictions. The single identifiable opportunity under this code—Seminole County's Naloxone procurement—appears misfiled and does not represent typical pharmaceutical procurement under the flunixin designation. Without additional recent opportunities from other counties, health departments, or veterinary agencies, this code shows limited current activity for business development purposes. Professionals should verify whether Flunixin itself is regularly purchased under a different UNSPSC designation or whether state and local governments' use of this specific code remains inactive.